CD20-targeted CAR-T therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CD20-targeted CAR-T therapy, covering 2019-06-25 to 2026-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study on in Vivo CAR-T Therapy Targeting CD20 for the Treatment of Hematological Malignancies [EARLY_Phase 1]